… constitutes the first line of obesity treatment. However, it is … have approved six different drugs
for obesity treatment: Orlistat [3,4,… It encompasses Cannabinoid receptors type 1 and 2 (CB1 …

… —that more realistically reflects the most common cause of human obesity. In the study,
mice that were made obese simply through the provision of a high-fat diet were treated …

… obesity. A double-blind, placebo-controlled, phase II trial using 4 months of rimonabant
treatment in a group of obese … cannabinoid CB1 receptor antagonist treatment in diet-induced …

… The authors found that in a rat model of diet-induced obesity (DIO), cannabis extract treatment
reduced the weight gain (mainly fat depots) and increased energy expenditure through …

… a new drug target for obesity treatment. … of cannabinoid receptor antagonists in obesity
management. First, the properties of an ideal anti-obesity drug will be described and cannabinoid …

… application of Cannabis sativa as a possible treatment for obesity. This … cannabis and
obesity, Cannabis sativa and obesity, THCV and obesity, Δ9-tetrahydrocannabidinol and obesity…

… Behavioural and cognitive treatments might be useful on an individual basis. However in …
-treatment baseline within a few years. The few existing approved drugs for treatment of obesity…

… contributors to obesity-induced insulin resistance and type 2 diabetes. This suggests new
approaches for cannabinoid-based therapy in the management of obesity and obesity-related …

… cannabinoid pharmacology and the aforementioned promotion of CB1 antagonists in an
antiobesity … whereby exogenous or endogenous cannabinoids promote eating. Remarkably, …

… Cannabinoid receptor-1 antagonists may influence weight by increasing energy expenditure.
Obese rats treated … weight throughout the 2-week treatment period, even when food intake …